Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mary-Claire King, Robert Hagemann


The Paul Ehrlich Foundation has awarded Mary-Claire King the €100,000 ($130,000) 2013 Paul Ehrlich Prize. King, a geneticist in the area of cancer and forensics, is a professor at the University of Washington.

She was awarded the prize for demonstrating that there is a genetic predisposition to breast cancer, specifically mutations found in the BRCA1 gene. The foundation said her efforts have a larger impact beyond breast cancer because she helped to show that genes are involved in complex, multifactorial diseases that also can be impacted by environmental and lifestyle factors.

Quest Diagnostics said that senior vice president and chief financial officer Robert Hagemann plans to leave the company at the end of May, and the firm is now searching internally and externally for a new CFO.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.